个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共7条记录   Impact of Safety-Related Regulatory Action on Clinical Practice A Systematic Review [作者：Piening, S; Haaijer-Ruskamp, FM; de Vries, JTN; van der Elst, ME; de Graeff, PA; Straus, SMJM; Mol, PGM,期刊：Drug safety, 页码：373-385 , 文章类型： Review，,卷期：2012年35-5] Background: After market approval, new serious safety issues are regularly identified for drugs that lead to regulatory action to inform healthcare professionals. However, the effectiveness of these safety-related regula... Promoting Spontaneous Adverse Drug Reaction Reporting in Hospitals Using a Hyperlink to the Online Reporting Form An Ecological Study in Portugal [作者：Ribeiro-Vaz, I; Santos, C; da Costa-Pereira, A; Cruz-Correia, R,期刊：Drug safety, 页码：387-394 , 文章类型： Article，,卷期：2012年35-5] Background: Spontaneous adverse drug reaction (ADR) reporting has been described as an efficient method to detect drug safety signals. However, under-reporting is a major issue undermining the effectiveness of spontaneou... A Pharmacoepidemiological Network Model for Drug Safety Surveillance Statins and Rhabdomyolysis [作者：Reis, BY; Olson, KL; Tian, L; Bohn, RL; Brownstein, JS; Park, PJ; Cziraky, MJ; Wilson, MD; Mandl, KD,期刊：Drug safety, 页码：395-406 , 文章类型： Article，,卷期：2012年35-5] Background: Recent withdrawals of major drugs have highlighted the critical importance of drug safety surveillance in the postmarketing phase. Limitations of spontaneous report data have led drug safety professionals to ... Early Steps in the Development of a Claims-Based Targeted Healthcare Safety Monitoring System and Application to Three Empirical Examples [作者：Wahl, PM; Gagne, JJ; Wasser, TE; Eisenberg, DF; Rodgers, JK; Daniel, GW; Wilson, M; Schneeweiss, S; Rassen, JA; Patrick, AR; Avorn, J; Bohn, RL,期刊：Drug safety, 页码：407-416 , 文章类型： Article，,卷期：2012年35-5] Background: Several efforts are under way to develop and test methods for prospective drug safety monitoring using large, electronic claims databases. Prospective monitoring systems must incorporate signalling algorithms... A Cohort Study Exploring Determinants of Safety-Related Regulatory Actions for Biopharmaceuticals [作者：Ebbers, HC; Mantel-Teeuwisse, AK; Moors, EHM; Tabatabaei, FAS; Schellekens, H; Leufkens, HGM,期刊：Drug safety, 页码：417-427 , 文章类型： Article，,卷期：2012年35-5] Background: The characteristics of biopharmaceuticals may require a tailored approach to their safety management. However, information on what tools and methods are employed to assess the safety of biopharmaceuticals pos... Defining 'Surveillance' in Drug Safety [作者：Aronson, JK; Hauben, M; Bate, A,期刊：Drug safety, 页码：347-357 , 文章类型： Article，,卷期：2012年35-5] The concept of surveillance in pharmacovigilance and pharmacoepidemiology has evolved from the concept of surveillance in epidemiology, particularly of infectious diseases. We have surveyed the etymology, usages, and pre... A Benefit-Risk Assessment of Dapoxetine in the Treatment of Premature Ejaculation [作者：Hutchinson, K; Cruickshank, K; Wylie, K,期刊：Drug safety, 页码：359-372 , 文章类型： Review，,卷期：2012年35-5] Premature ejaculation (PE) is considered to be the most common sexual problem affecting men, despite the likelihood that it is under-diagnosed. It is a complex condition with many physical and psychological components, m...